[NFS-02] Neuroscience Frontier Symposium 02
Original discovery and therapy for SCA from Japan to the world

[NFS-02-2] Current clinical characteristics of Asidan (SCA36)

^○Yasuyuki Ohta (Department of Neurology, Okayama University, Japan)

Spinocerebellar ataxia (SCA) is neurodegenerative diseases affecting mainly cerebellum and brainstem, and new subtypes and pathologies of SCAs have been continuously discovered in the world. Especially, SCA31 and SCA36 (nicknamed Asidan) were first found in Japanese, and their clinical and pathological features are quite unique compared with other SCAs. Recent discovery of repeat associated non-ATG (RAN) translation in the pathogenesis of hereditary SCAs carrying repeat expansion mutations has tremendously extended our understanding in the pathogenesis of SCA and other neurodegenerative diseases. Furthermore, the development of new therapy for SCAs have been extensively investigated in Japan and the world. The aim of this symposium is to learn and discuss the current clinical, pathological and therapeutic findings of SCAs for Japanese and Asian neurologists and neuroscientists.

1994 – 2000 Faculty of Medicine, Okayama University
2000 – 2002 Resident, Department of Neurology, Okayama University Hospital and
Department of Internal Medicine, Okayama Rousai Hospital
2002 – 2007 Research fellow, Department of Neurology, Okayama University Hospital
2007 – 2010 Physician, Department of Neurology, Ota Memorial Hospital,
Kurashiki Heisei Hospital and Okayama University Hospital
2010－2014 Postdoctoral fellow, Faculty of Medicine, l'université Laval
2014－2015 Assistant Professor, Department of Neurology,
Okayama University Hospital
2015－ Senior Lecturer, Department of Neurology, Okayama University Hospital

Research Interests: Molecular mechanisms and clinical research of neurological disorders